Featured Research

from universities, journals, and other organizations

Low HDL-cholesterol: Not quantity, but quality

Date:
April 30, 2013
Source:
Helsingin yliopisto (University of Helsinki)
Summary:
Many of the genes regulating the inflammation and immune response of the body are also associated with low HDL-cholesterol levels in the circulation, tells the recent study. The research also discovered that the quality of HDL particle can vary considerably. Cholesterol is a major risk factor for heart disease. Elevated LDL-cholesterol, commonly known as the ‘bad cholesterol,’ is associated with the increased risk of heart disease while HDL-cholesterol, the ‘good cholesterol’, is associated with decreased risk.

Functions of the HDL particle that protect against heart disease.
Credit: University of Helsinki

Many of the genes regulating the inflammation and immune response of the body are also associated with low HDL-cholesterol levels in the circulation, tells the recent study conducted at the University of Helsinki, Finland. The research also discovered that the quality of HDL particle can vary considerably.

Related Articles


Cholesterol is a major risk factor for heart disease. Elevated LDL-cholesterol, commonly known as the 'bad cholesterol,' is associated with the increased risk of heart disease while HDL-cholesterol, the 'good cholesterol', is associated with decreased risk.

During the past few years, approximately 40 regions in the genome have been associated with plasma HDL-cholesterol levels. In a recent publication, the genetic background of low HDL-cholesterol was studied by research groups from the University of Helsinki, Finland. The study subjects were Finnish individuals with either extremely high or extremely low HDL-cholesterol.

The scientists discovered several new genes which predispose low HDL-cholesterol levels. They also observed that many of the genes regulating inflammation and immune response of the body were also associated with low HDL-cholesterol levels in the circulation. The results thus validate the strong link between inflammation and low HDL-cholesterol.

"The results of the study tell us that some individuals are genetically more prone to inflammation than others, especially in the adipose tissue and blood vessels. The inflammation may block the transport of cholesterol from vessel walls to circulation leading to lower HDL-cholesterol levels in the circulation," says Dr. Pirkka-Pekka Laurila.

'Good' is not always that good

The researchers also showed that the quality of HDL particle can vary considerably. In individuals, whose HDL-cholesterol levels were low, the quality of HDL particles was also impaired; they contained smaller amounts of lipid molecules which are known to be antioxidant and thus protective to arteries. In individuals with high HDL-cholesterol levels in the circulation, the lipid composition of the HDL particle was more beneficial regarding heart disease risk.

Based on this Finnish study, and earlier ones, the terms 'HDL-cholesterol' and 'HDL particle' should not be confused to indicate heart disease risk. The term 'good cholesterol' appears to be misleading as the cholesterol molecules is exactly the same in both 'good' HDL and 'bad' LDL particles. It is likely that molecules other than cholesterol -- the lipid and protein molecules on the surface of the HDL particle -- are responsible for the protective effects of HDL particles against heart disease.

This study was conducted in collaboration with research groups led by Professors Marja-Riitta Taskinen, Matti Jauhiainen, Matej Orešič, and Samuli Ripatti.

Cholesterol is a molecule which is transported in the circulation by its carriers, the HDL particles and LDL particles. HDL particles remove cholesterol from the blood vessel walls and transport it to the liver to be excreted from the body via bile. LDL particles transport cholesterol to the organs of the body from the blood stream. If LDL-cholesterol levels are elevated in the blood stream, cholesterol will accumulate in the vessel wall leading to plaque formation in the vessels (atherosclerosis).


Story Source:

The above story is based on materials provided by Helsingin yliopisto (University of Helsinki). Note: Materials may be edited for content and length.


Journal Reference:

  1. P.-P. Laurila, I. Surakka, A.-P. Sarin, L. Yetukuri, T. Hyotylainen, S. Soderlund, J. Naukkarinen, J. Tang, J. Kettunen, D. B. Mirel, J. Soronen, T. Lehtimaki, A. Ruokonen, C. Ehnholm, J. G. Eriksson, V. Salomaa, A. Jula, O. T. Raitakari, M.-R. Jarvelin, A. Palotie, L. Peltonen, M. Oresic, M. Jauhiainen, M.-R. Taskinen, S. Ripatti. Genomic, Transcriptomic, and Lipidomic Profiling Highlights the Role of Inflammation in Individuals With Low High-density Lipoprotein Cholesterol. Arteriosclerosis, Thrombosis, and Vascular Biology, 2013; 33 (4): 847 DOI: 10.1161/ATVBAHA.112.300733

Cite This Page:

Helsingin yliopisto (University of Helsinki). "Low HDL-cholesterol: Not quantity, but quality." ScienceDaily. ScienceDaily, 30 April 2013. <www.sciencedaily.com/releases/2013/04/130430091629.htm>.
Helsingin yliopisto (University of Helsinki). (2013, April 30). Low HDL-cholesterol: Not quantity, but quality. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2013/04/130430091629.htm
Helsingin yliopisto (University of Helsinki). "Low HDL-cholesterol: Not quantity, but quality." ScienceDaily. www.sciencedaily.com/releases/2013/04/130430091629.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins